InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,280.80
(
0.34%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.46
(
1.17%
)
Bitcoin
61,453.76
(
1.05%
)
Post# of 4973156
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

budfoxfun

Send PM Follow Ignore
Followers 971
Posts 383037
Boards Moderated 6
Alias Born 06/24/2011

budfoxfun

Re: None

Friday, 12/29/2023 12:22:02 PM

Friday, December 29, 2023 12:22:02 PM

Post# of 4973156
$RNXT RenovoRx today announced the acceptance of a clinical data abstract for the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting, held March 23-28 in Salt Lake City, Utah. The abstract will highlight the Company’s lead product candidate, RenovoGem™, and proprietary Trans-Arterial Micro-Perfusion (TAMP) therapy platform for the treatment of Locally Advanced Pancreatic Cancer (LAPC), a difficult-to-access, solid tumor cancer. For details: https://bit.ly/3NAWc74

#SIR24SLC #PancreaticCancer #LocallyAdvancedPancreaticCancer #LAPC https://www.linkedin.com/posts/renovorx_sir24slc-pancreaticcancer-locallyadvancedpancreaticcancer-activity-7142871521638699008-S4DW?utm_source=share&utm_medium=member_desktop
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up